Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface
|
|
|
- Camron Spencer
- 10 years ago
- Views:
Transcription
1 Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface Kathleen Brady, M.D., Ph.D. Professor of Psychiatry Associate Dean of Clinical and Translational Research Medical University of South Carolina
2 Thanks to My Colleagues and NIH
3 Traumatic Exposure Common in the Lives of Individuals with SUDs
4 Clinical Evidence for Stress- Relapse Connection Intuitive appeal, but methodologic issues Definition of stressor Causal relationship difficult to establish Childhood adverse events strongly associated with SUD s PTSD, mood/anxiety disorders strongly associated with SUD s
5 PTSD and Substance Use Disorders Treatment seeking individuals PTSD % have substance use disorders maybe higher in combat-related PTSD Substance use samples % have PTSD - higher in women, cocaine/opiate users Epidemiologic data Significantly increased odds ratios
6 Non-Random Association
7 Neurochemical Response to Stress Hypothalamic-Pituitary-Adrenal axis Extra-Hypothalamic CRH systems Locus Coeruleus-Norepinephrine Dopamine Systems Serotonin Systems GABA Systems Glutamate Systems
8
9 Adaptive Allostatic Response McKewen, B. NEJM 1998; 338:171-79
10 Stress Response Allostasis vs. Homeostasis Homeostasis - tightly controlled physiology parameters Allostasis - Adaptive response to stress Recruitment of all available physiological, psychological and behavioral resources McKewen,B. NEJM 1998;338:171-79
11 Homeostasis versus Allostasis
12
13 Animal Models of Relapse: Reinstatement (Relapse) Resumption of previously drug-reinforced behavior by non-contingent exposure to drug or non-drug stimuli Self-administration training Extinction Test for reinstatement under various conditions» dewit and Stewart, 1981;» Psychopharmacology (2003), Volume 168
14 Reinstatement Models Drug-primed reinstatement: low dose drug administration Cue-induced reinstatement: environmental cues associated with drug use Stress-induced reinstatement: foot shock, forced swim, isolation, immobilization, etc.
15 Stress-Induced Reinstatement: Pharmacologic and Surgical Manipulation Blocked by CRF antagonists Induced by CRF agonists Blockade of B-receptors in amygdala and BNST blocks stress-induced reinstatement Increased by amount of previous drug exposure Cue-induced reinstatement increased by stress
16 Stress Response in Drug Dependent Individuals Acute withdrawal from all drugs of abuse - activation of HPA axis Dysregulation of HPA axis/abnormal stress response persists for weeks to months? Dysregulation associated with early life trauma? Role of dysregulation in drug craving/relapse» Kreek and Koob, 2006
17 Human Laboratory Studies Stress Exposure Psychological - Trier Physical Cold Pressor Pharmacologic CRF, Yohimbine Drug-cue Exposure Measurement Craving (proxy for use) ACTH/cortisol Physiologic parameters
18 Craving and Stress Increase in Response to CRF
19 Heart Rate Responding to CRF (Cocaine x Gender: P = 0.05)
20 Correlation Between ACTH and Cortisol in Cocaine Dependence Control Males Control Females Cocaine Dependent Males Cocaine Dependent Females
21 Relationship Between Stress Response and Relapse???
22 Back et al., 2010 Relationship Between CRH-induced Craving/Stress and Relapse
23 Probability of Relapse Based on % Cortisol Change from Baseline
24 CONCLUSIONS Elevated craving and stress to CRH and drug cues associated with relapse Attenuated ACTH/cortisol response to CRH associated with relapse
25 ? Impact of Early Trauma on Stress Reactivity/Addiction
26 Childhood Sexual Abuse and Psychiatric Disorders in Women Abuse positively associated with a number of disorders Strongest relationship with alcohol/drug use More severe abuse increases risk Not explained by background/familial factors Kendler et. al, 2000
27 Adverse Childhood Experiences (ACE) and Illicit Drug Use (n = 8603) 10 Drug Initiation < 14 years of age 10 Ever Addicted Odds Ratio ACE Score Odds ratio ACE Score ACE account for one half to two third of serious problems with drug use. PEDIATRICS 111: , 2003
28 Does Stress Alter Reward Sensitivity before Development of Addiction?
29 Effects of Childhood Trauma on Reward Sensitivity (Jia et al.) 36 light to moderate social drinkers. Two risk groups (HR vs LR) on the basis of high and low ratings on Childhood Trauma Questionnaire (CTQ, Bernstein et al., 1998). Exposed to 2 stress, 2 alcohol cue and 2 neutral relaxed trials presented during fmri
30 Neural Response to Stress in Healthy Adults with High vs Low Childhood Trauma Nucleus Accumbens/Striatum Individuals with greater childhood trauma (HR) showed greater nucleus accumbens/striatum (reward) activity with stress and with neutral relaxing stimuli compared to LR group. CTQ scores correlated positively with this NAcc activity (p<.01).
31 Significant Correlation between NAcc Activity (right) during Stress with Age of First Substance Use Left NAcc Activity under Stress R 2 = 0.21, R = -0.46, p < 0.01 Right NAcc Activity under Stress R 2 = 0.28, R = -0.53, p < Age of Onset of Substance Use Age of Onset of Substance Use
32 How do early experiences produce long-lasting changes in vulnerability to the development of addictions and other disorders??????
33 Mean Stress-Induced Changes in Dopamine Signals in Core Region of Nucleus Accumbens of Maternally Separated & Handled Animals Brake et al., 2004
34 Mean Changes in Locomotor Activity following Injection of Saline or Cocaine Brake et al., 2004
35 Epigenetics Environmentallyinduced changes in DNA expression Methylation, acetylation of histones impacts transcription Gene-by-environment interactions CRF polymorphisms
36 Impact of Negative Life Experience on Alcohol Consumption Depends on CRF Polymorphism Percentage of lifetime heavy drinking adjusted for sex in adolescents grouped by genotype and exposure to negative life events. Blomeyer, et al., 2008 Biol Psychiatry
37 Mean Alcohol Consumption by H1/H2 haplotype and CSA status Nelson et al., 2010 Addict Biol
38 Charney, Am J Psychiatry, 2002
39 OXYTOCIN Regulates lactation Promotes affiliative behavior Anxiolytic, released in response to stress Decreases HPA and fight or flight response
40 Interaction of Social Support and Oxytocin on Stress Response 37 healthy males Trier Social Stress Test Social support from friend during preparation Intranasal oxytocin (24 IU) before task Measure cortisol, subjective effects» Heinrichs et al., 2003
41 Heinrichs et al., 2003 Social Support and Oxytocin in Psychosocial Stress Task
42 OXYTOCIN AND MARIJUANA/COCAINE CRAVING Pilot human laboratory studies Intranasal administration of oxytocin versus placebo Trier Social Stress Task Decreased cortisol Decreased stress response Decreased craving Mcrae et al, in press
43 PTSD and SUBSTANCE USE DISORDERS Little empirical evidence to guide treatment: Traditional substance use programs defer treatment of trauma related issues PTSD programs don t accept individuals with active substance use disorders
44 Psychotherapeutic Treatments Cognitive-behavioral therapies efficacious in both PTSD and substance use disorders Manualized integrated treatments promising Relapse prevention + stress inoculation + exposure (Triffleman et al., 1999) Imaginal exposure + relapse prevention (Brady et al., 2002) Education + relapse prevention + coping skills ( Seeking Safety, Najavits et al, 2002)
45 Seeking Safety in CTN:Trauma Severity (N=353) Mean Severity Hien et al. (in press). Multi-site randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders, Journal of Consulting and Clinical Psychology.
46 Temporal Course of Improvement in PTSD/SUD Investigate relationship between improvements in PTSD and substance use during 12 week treatment phase PTSD improve SUD improve SUD improvement not associated with PTSD improvement» Hein et al, 2010
47 Concurrent Treatment with Prolonged Exposure (COPE) 12 sessions, manual guided, individual therapy First 4 sessions CBT for cocaine - education re: trauma response/ PTSD Sessions 5-12 exposure Brady, Back, Foa, Carroll
48 COPE Clinical Trials University of New South Wales: 120 individuals with drug dependence/ptsd, compared to treatment as usual Columbia University: 120 individuals, compared with Relapse Prevention CBT MUSC: OEF/OIF Veterans
49 Severity of dependence Mean Baseline 6 wks 3mths 9 mths Control Treatment
50 Severity of PTSD symptoms Mean CAPS score Baseline 6 wks 3mths 9 mths Control Treatment A reduction of 15 points on the CAPS total score is considered clinically significant
51 Effects of Stress/Trauma On Substance Use Disorders 1. Facilitate initiation 2. Increase risk of developing addiction after initiation 3. Trigger relapse
52 Biology/Genes Environment DRUG Neurobiology Addiction
53 Stress and Substance Use Disorders: Clinical Considerations Careful assessment/aggressive treatment of co-occurring stress sensitive disorders Importance of social support in mediating effects of stress Careful attention to environmental factors ongoing stress/abuse Coping Skills/Stress Management Techniques
54 CONCLUSIONS Relationship between stress and substance use/relapse, development of dependence Mechanistic studies important Identification of new avenues for treatment development
55
Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives
Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives Neurobehavioral Aspects of Alcohol Consumption Source: Eighth Special Report to the U.S. Congress on Alcohol and Health Secretary
Co-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
Addiction Neurobiology
Addiction Neurobiology Stephen Jurd University of Sydney Australia Richard W is sick Apology The site of pathology IF Addiction has a neurobiological basis THEN we should be able to: Define addiction AND
Alcohol Overuse and Abuse
Alcohol Overuse and Abuse ACLI Medical Section CME Meeting February 23, 2015 Daniel Z. Lieberman, MD Professor and Vice Chair Department of Psychiatry George Washington University Alcohol OVERVIEW Definitions
OVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
What Can Science Contribute to the Treatment of Alcoholism?
What Can Science Contribute to the Treatment of Alcoholism? George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Flow of Talk 1. Conceptual Framework
Tolerance and Dependence
Tolerance and Dependence Drug Tolerance is a decrease in the effect of a drug as a consequence of repeated exposure. Change over repeated exposures. Different effects may show different tolerance. Tolerance
Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis, MD, MPH
CBT for Youth with Co-Occurring Post Traumatic Stress Disorder and Substance Disorders Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis,
Testing Mediators of Topiramate s Effects on Alcohol Use Using Ecological Momentary Assessment Methods
Testing Mediators of Topiramate s Effects on Alcohol Use Using Ecological Momentary Assessment Methods Robert Miranda Jr., Ph.D. Associate Professor of Psychiatry and Human Behavior Center for Alcohol
MOBC Research Highlights Reel. Mitch Karno Mechanisms of Behavior Change Conference San Antonio, Texas June 20, 2015
MOBC Research Highlights Reel Mitch Karno Mechanisms of Behavior Change Conference San Antonio, Texas June 20, 2015 Starring -Change Talk -Attentional Bias -Self-Efficacy -Social Network -Craving Study
Treatment of PTSD and Comorbid Disorders
TREATMENT GUIDELINES Treatment of PTSD and Comorbid Disorders Guideline 18 Treatment of PTSD and Comorbid Disorders Description Approximately 80% of people with posttraumatic stress disorder (PTSD) have
Treatment of Combat-related PTSD with Virtual Reality Exposure Therapy
Treatment of Combat-related PTSD with Virtual Reality Exposure Therapy LTC(P) Michael J. Roy, M.D., M.P.H. Director, Division of Military Medicine Professor of Medicine Uniformed Services University Bethesda,
Recognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
Beroendemekanismer- ett beroende som andra?
Beroendemekanismer- ett beroende som andra? Neuroendokrina responser till spel om pengar Anna Söderpalm Gordh Dopamine and the Rewardsystem Studies in animal models have demonstrated that mesocorticolimbic
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH
NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH Disclosures This presentation does not represent the views of the US Public Health Service or the US Food and Drug Administration The majority
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
12 Steps to Changing Neuropathways. Julie Denton
12 Steps to Changing Neuropathways Julie Denton Review the neurobiology of the brain Understand the basics of neurological damage to the brain from addiction Understand how medications and psychotherapy
Chapter 9: Drug Abuse and Addiction
Chapter 9: Drug Abuse and Addiction Drug use and abuse- some history Drug addiction: Defining terms Physical dependence/ drug withdrawal Factors that influence development and maintenance of drug addiction
Patients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
American Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement: Definition of Addiction (Long Version) Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.
Minnesota Co-occurring Mental Health & Substance Disorders Competencies:
Minnesota Co-occurring Mental Health & Substance Disorders Competencies: This document was developed by the Minnesota Department of Human Services over the course of a series of public input meetings held
African American Women and Substance Abuse: Current Findings
African American Women and Substance Abuse: Current Findings Based on the work of Amelia Roberts, Ph.D. Assistant Professor, UNC School of Social Work and Iris Carleton-LeNay, Ph.D. Professor, UNC School
Cognitive Behavioral Therapy for PTSD. Dr. Edna B. Foa
Cognitive Behavioral Therapy for PTSD Presented by Dr. Edna B. Foa Center for the Treatment and Study of Anxiety University of Pennsylvania Ref # 3 Diagnosis of PTSD Definition of a Trauma The person has
WHAT HAPPENS TO OUR BRAIN?
WORK DYNAMIC The final result of this session is the formulation of the questions that, within the activity of the Let s talk about drugs programme of the la Caixa Welfare Project, you will ask Dr. Rafael
Medication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
2) Recurrent emotional abuse. 3) Contact sexual abuse. 4) An alcohol and/or drug abuser in the household. 5) An incarcerated household member
Co Occurring Disorders and the on Children: Effectively Working with Families Affected by Substance Abuse and Mental Illness Definition (Co-Occurring also called Dual Dx) A professional diagnosis of addictive/substance
Dual Diagnosis. Location: VA Boston Healthcare System, Brockton Campus
Track Director: Justin Enggasser, Ph.D. Psychology Service (116B) 940 Belmont Street Brockton, MA 02301 Telephone: (774) 826-1380 Email: [email protected] Dual Diagnosis Location: VA Boston Healthcare
Office-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
Chronic Stress, Drug Use, and Vulnerability to Addiction
Chronic Stress, Drug Use, and Vulnerability to Addiction Rajita Sinha Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA Stress is a well-known risk factor in the
Addiction Medicine 2014
Addiction Medicine 2014 Update on Current/New/Anticipated Medications for Alcohol Use Disorders J.C. Garbutt, MD Department of Psychiatry and Bowles Center for Alcohol Studies School of Medicine, University
Using Mechanisms of Extinction and Reconsolidation for the Treatment of Drug Addiction. Ali Longstreet. University of Calgary
Running head: EXTINCTION AND RECONSOLIDATION Using Mechanisms of Extinction and Reconsolidation for the Treatment of Drug Addiction Ali Longstreet University of Calgary EDPS 646: Processes of Learning
Kathleen T. Brady, M.D., Ph.D., and Susan C. Sonne, Pharm.D.
The Role of Stress in Alcohol Use, Alcoholism Treatment, and Relapse Kathleen T. Brady, M.D., Ph.D., and Susan C. Sonne, Pharm.D. Addiction to alcohol or other drugs (AODs) is a complex problem determined
Naltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
Assessing families and treating trauma in substance abusing families
Children, Trauma and the impact of Substance abuse Day One Outpatient (874-1045) Amy Stevenson LCPC CCS ([email protected]) Don Burke LCPC CCS ([email protected]) Assessing families and treating trauma in
MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT
MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT June, 2014 Dean L. Babcock, LCAC, LCSW Associate Vice President Eskenazi Health Midtown Community Mental Health Centers Why is Evidence-Based
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair Michael Fishman, MD Director of Young Adult Program How Addiction Takes Hold Large & rapid upsurges in dopamine
Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1
Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1 Disclosure Statement Prevalence of Opioid Addiction 100 Individuals Die Every
Traumatic Stress. and Substance Use Problems
Traumatic Stress and Substance Use Problems The relation between substance use and trauma Research demonstrates a strong link between exposure to traumatic events and substance use problems. Many people
WHAT IS PTSD? A HANDOUT FROM THE NATIONAL CENTER FOR PTSD BY JESSICA HAMBLEN, PHD
WHAT IS PTSD? A HANDOUT FROM THE NATIONAL CENTER FOR PTSD BY JESSICA HAMBLEN, PHD Posttraumatic Stress Disorder (PTSD) is an anxiety disorder that can occur following the experience or witnessing of a
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse
DSM-IV Alcohol Dependence Alcohol and Drug Abuse David Gilder, MD Division of Mental Health Scripps Clinic Alcohol Research Center The Scripps Research Institute 1.5.11 Three or more criteria, same 12
Hortensia Amaro, Ph.D. Institute on Urban Health Research Northeastern University
The Boston Consortium Model: Treatment of Trauma Among Women with Substance Use Disorders Hortensia Amaro, Ph.D. Institute on Urban Health Research Northeastern University 1. Background of the Problem
Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial
Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial Barbara J. Mason, Ph.D. Professor, Committee on the Neurobiology of Addictive Disorders Director, Laboratory of Clinical Psychopharmacology
Frequently Asked Questions (FAQs) of Drug Abuse Treatment for Criminal Justice Populations
Frequently Asked Questions (FAQs) of Drug Abuse Treatment for Criminal Justice Populations From The National Institute on Drug Abuse (NIDA) 2. Why should drug abuse treatment be provided to offenders?
Rogers Memorial Hospital (Wisconsin).
Bradley C. Riemann, Ph.D. Clinical Director, OCD Center and CBT Services Rogers Memorial Hospital The Use of Exposure and Ritual Prevention with OCD: Key Concepts and New Directions OCD Center Rogers Memorial
Health on the Homefront: PTSD, Its Clinical Description, Treatment and Underlying Pathophysiology
Health on the Homefront: Stephen I. Deutsch, M.D., Ph.D. Eastern Virginia Medical School World War I Shell Shock and Disordered Action of the Heart Tremors Tics Fatigue Memory loss Difficulty in sleeping
Substance Addiction. A Chronic Brain Disease
Substance Addiction A Chronic Brain Disease What you will Learn Addiction is a Brain Disease Understand the Structure and Pathways Associated with changes in the brain. Addiction is a Chronic Condition
Martha Brewer, MS, LPC,LADC. Substance Abuse and Treatment
Martha Brewer, MS, LPC,LADC Substance Abuse and Treatment What is a substance use disorder? Long-term and chronic illness Can affect anyone: rich or poor, male or female, employed or unemployed, young
TIP Prospectus for Concept Clearance Substance Abuse Treatment and Trauma
TIP Prospectus for Concept Clearance Substance Abuse Treatment and Trauma Introduction The events of September 11, 2001, have reminded Americans that they are vulnerable to international terrorism and
AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS
AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS BARRY J. EVERITT Department of Experimental Psychology, University of Cambridge Stimulant drugs, such as cocaine and amphetamine, interact directly with dopamine
Adversity, Toxic Stress & Resiliency. Baystate Medical Center:Family Advocacy Center Jessica Wozniak, Psy.D., Clinical Grants Coordinator
Adversity, Toxic Stress & Resiliency Baystate Medical Center:Family Advocacy Center Jessica Wozniak, Psy.D., Clinical Grants Coordinator Adverse Childhood Experiences ACE Study (www.acestudy.org) 18,000
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
Using Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
Preventing & Treating Substance Abuse Based Trauma in Families. National Council on Alcoholism and Drug Dependence, Sacramento
Preventing & Treating Substance Abuse Based Trauma in Families WHY FACING THE TIGER EMPOWERS INDIVIDUALS, FAMILIES AND THE COMMUNITIES THEY LIVE IN The Nature of Trauma Traumatic experience defined Points
Learning Objectives Review and discuss current research on the basic brain physiology of addiction
Emerging Trends in Addiction Treatment 1.0 CE NBCC, NAADAC, FCB Dr. Doug Davies, MD, ASAM Medical Director The Refuge A Healing Place, Ocklawaha, FL 14835 SE 85 th Street Ocklawaha, FL 32179 www.therefuge
SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013
SC 215 FIGHTING DRUG ADDICTION WITH DRUGS John Bush April 15, 2013 ADDICTION A persistent, compulsive dependence on a behavior or substance Behavioral Compulsive shopping --Compulsive eating Compulsive
1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
UNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015
UNDERSTANDING CO-OCCURRING DISORDERS Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015 CO-OCCURRING DISORDERS What does it really mean CO-OCCURRING
Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia
Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE
The Forgotten Worker: Veteran
The Forgotten Worker: Veteran Larry Ashley & Meghan Pierce University of Nevada, Las Vegas Veteran Workforce Statistics The unemployment rate of veterans from all eras is 8.7% (Bureau of Labor Statistics,
Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
OCD & Anxiety: Helen Blair Simpson, M.D., Ph.D.
OCD & Anxiety: Symptoms, Treatment, & How to Cope Helen Blair Simpson, M.D., Ph.D. Professor of Clinical Psychiatry, Columbia University Director of the Anxiety Disorders Clinic, New York State Psychiatric
Assessment of depression in adults in primary care
Assessment of depression in adults in primary care Adapted from: Identification of Common Mental Disorders and Management of Depression in Primary care. New Zealand Guidelines Group 1 The questions and
The Adverse Health Effects of Cannabis
The Adverse Health Effects of Cannabis Wayne Hall National Addiction Centre Kings College London and Centre for Youth Substance Abuse Research University of Queensland Assessing the Effects of Cannabis
Seminar/Talk Calendar
Seminar/Talk Calendar Tuesday, February 3rd Dr. John Neumaier, Professor of Psychiatry and Pharmacology, University of Washington DREADDing Addiction Dr. Neumaier s laboratory is studying stress and addiction
fmri studies of addiction and relapse Rebecca Elliott Bill Deakin Anna Murphy Neuroscience and Psychiatry Unit
fmri studies of addiction and relapse Rebecca Elliott Bill Deakin Anna Murphy Neuroscience and Psychiatry Unit Background Previous PhD projects on brain basis of craving: Lesley Peters and Dan Lubman Expertise
Cognitive Behavioral Interventions for Substance Abuse. Overview Presentation TASC Conference 2013. University of Cincinnati Corrections Institute
Cognitive Behavioral Interventions for Substance Abuse Overview Presentation TASC Conference 2013 University of Cincinnati Corrections Institute Curriculum Content, Format and Supporting Research Curriculum
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community Dr David Jackson Clinic Medical Officer The Hobart Clinic Association Drugs In tonight s context, drugs
Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
OVERVIEW OF COGNITIVE BEHAVIORAL THERAPY. 1 Overview of Cognitive Behavioral Therapy
OVERVIEW OF COGNITIVE BEHAVIORAL THERAPY 1 Overview of Cognitive Behavioral Therapy TABLE OF CONTENTS Introduction 3 What is Cognitive-Behavioral Therapy? 4 CBT is an Effective Therapy 7 Addictions Treated
John Viernes, Jr. Executive Director. Substance Abuse Prevention and Control (SAPC) Los Angeles County Department of Public Health
Extended-Release Injectable Naltrexone (Vivitrol) Pilot Project in Los Angeles County John Viernes, Jr. Executive Director Substance Abuse Prevention and Control (SAPC) Los Angeles County Department of
GOING BEYOND FOSTER CARE
GOING BEYOND FOSTER CARE Sharon W. Cooper, MD Developmental & Forensic Pediatrics, P.A. University of North Carolina Chapel Hill School of Medicine [email protected] OBJECTIVES Adverse childhood
information for service providers Schizophrenia & Substance Use
information for service providers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 2 3 5 6 7 8 9 How prevalent are substance use disorders among people with schizophrenia? How prevalent
Treatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
ADOLESCENT CO-OCCURRING DISORDERS: TREATMENT TRENDS AND GUIDELINES AMANDA ALKEMA, LCSW BECKY KING, LCSW ERIC TADEHARA, LCSW
ADOLESCENT CO-OCCURRING DISORDERS: TREATMENT TRENDS AND GUIDELINES AMANDA ALKEMA, LCSW BECKY KING, LCSW ERIC TADEHARA, LCSW INTRODUCTION OBJECTIVES National and Utah Statistics Best Practice Guidelines
Meditation as Viable
"Treatment of the Relapse Process using Mindfulness and Meditation as Viable Techniques" Christopher Shea, MA, CRAT, CAC-AD, LCC Adjunct Professor, Towson University Dir. Campus Ministry, St. Mary's Ryken
Donald Stephen Leitner
Donald Stephen Leitner Department of Psychology Office: (610)660-1802 Saint Joseph s University Fax: (610)660-1819 5600 City Avenue e-mail: [email protected] Philadelphia, PA 19131-1395 Laboratory: Post
"BARRIERS TO HIV PREVENTION AND CARE DUE TO CONSUMER SUBSTANCE ABUSE AND CHEMICAL DEPENDENCE PART II.
"BARRIERS TO HIV PREVENTION AND CARE DUE TO CONSUMER SUBSTANCE ABUSE AND CHEMICAL DEPENDENCE PART II. BY PROFESSOR TERENCE MCPHAUL PSYCHOLOGY TELEVISION NETWORK (PSYCHTV ) Distinct Populations of Youth
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment Background Studies show that more than 50% of patients who have been diagnosed with substance abuse
Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University
Diseases of the Nervous System Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University Outline A. Stress-related Disorders 1. Emotional Circuitry: Key Components 2. The Hypothalamic
ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION. Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research
ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research Department of Psychiatry, University of Minnesota & Mentor
Alcohol Expectancy Challenges: A Comprehensive Review
Alcohol Expectancy Challenges: A Comprehensive Review Khatidja S. Ali, M.A. Leslie A. Robinson, Ph.D. Ashley M. Hum, M.S. Ashley A. Jackson, M.S. The Department of Psychology The University of Memphis,
Managing Chronic Pain in Adults with Substance Use Disorders
Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which
NIAA Research Findings
NIAA Research Findings Summary: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Research Findings Orientation to Naltrexone and the Integration of Medication into State Treatment Systems. Posted
substance abuse and addiction are complex phenomena
Executive Summary 1 substance abuse and addiction are complex phenomena that defy simple explanation or description. A tangled interaction of factors contributes to an individual s seeking out, using,
